200 related articles for article (PubMed ID: 33997022)
1. Increase in Free Hepatic Venous Pressure Response to Beta-Blockers Predicts Variceal Bleeding in Cirrhotic Patients.
Guo H; Xiao J; Wang Y; Zhang M; Zhuge Y; Zhang F
Biomed Res Int; 2021; 2021():5587566. PubMed ID: 33997022
[TBL] [Abstract][Full Text] [Related]
2. Acute hemodynamic response to beta-blockers and prediction of long-term outcome in primary prophylaxis of variceal bleeding.
Villanueva C; Aracil C; Colomo A; Hernández-Gea V; López-Balaguer JM; Alvarez-Urturi C; Torras X; Balanzó J; Guarner C
Gastroenterology; 2009 Jul; 137(1):119-28. PubMed ID: 19344721
[TBL] [Abstract][Full Text] [Related]
3. Correlation of HVPG level with ctp score, MELD Score, ascites, size of varices, and etiology in cirrhotic patients.
Ramanathan S; Khandelwal N; Kalra N; Bhatia A; Dhiman RK; Duseja AK; Chawla YK
Saudi J Gastroenterol; 2016; 22(2):109-15. PubMed ID: 26997216
[TBL] [Abstract][Full Text] [Related]
4. Application of a standardised protocol for hepatic venous pressure gradient measurement improves quality of readings and facilitates reduction of variceal bleeding in cirrhotics.
Tey TT; Gogna A; Irani FG; Too CW; Lo HG; Tan BS; Tay KH; Lui HF; Chang PE
Singapore Med J; 2016 Mar; 57(3):132-7. PubMed ID: 26996384
[TBL] [Abstract][Full Text] [Related]
5. Hemodynamic response to primary prophylactic therapy with nonselective β-blockers is related to a reduction of first variceal bleeding risk in liver cirrhosis: a meta-analysis.
Kerbert AJ; Chiang FW; van der Werf M; Stijnen T; Slingerland H; Verspaget HW; van Hoek B; Coenraad MJ
Eur J Gastroenterol Hepatol; 2017 Apr; 29(4):380-387. PubMed ID: 28002118
[TBL] [Abstract][Full Text] [Related]
6. The hemodynamic response to medical treatment of portal hypertension as a predictor of clinical effectiveness in the primary prophylaxis of variceal bleeding in cirrhosis.
Merkel C; Bolognesi M; Sacerdoti D; Bombonato G; Bellini B; Bighin R; Gatta A
Hepatology; 2000 Nov; 32(5):930-4. PubMed ID: 11050041
[TBL] [Abstract][Full Text] [Related]
7. Carvedilol for primary prophylaxis of variceal bleeding in cirrhotic patients with haemodynamic non-response to propranolol.
Reiberger T; Ulbrich G; Ferlitsch A; Payer BA; Schwabl P; Pinter M; Heinisch BB; Trauner M; Kramer L; Peck-Radosavljevic M;
Gut; 2013 Nov; 62(11):1634-41. PubMed ID: 23250049
[TBL] [Abstract][Full Text] [Related]
8. Hemodynamic Effects of Adding Simvastatin to Carvedilol for Primary Prophylaxis of Variceal Bleeding: A Randomized Controlled Trial.
Vijayaraghavan R; Jindal A; Arora V; Choudhary A; Kumar G; Sarin SK
Am J Gastroenterol; 2020 May; 115(5):729-737. PubMed ID: 32079861
[TBL] [Abstract][Full Text] [Related]
9. Prognostic value of acute hemodynamic response to i.v. propranolol in patients with cirrhosis and portal hypertension.
La Mura V; Abraldes JG; Raffa S; Retto O; Berzigotti A; García-Pagán JC; Bosch J
J Hepatol; 2009 Aug; 51(2):279-87. PubMed ID: 19501930
[TBL] [Abstract][Full Text] [Related]
10. Prevention of Rebleeding From Esophageal Varices in Patients With Cirrhosis Receiving Small-Diameter Stents Versus Hemodynamically Controlled Medical Therapy.
Sauerbruch T; Mengel M; Dollinger M; Zipprich A; Rössle M; Panther E; Wiest R; Caca K; Hoffmeister A; Lutz H; Schoo R; Lorenzen H; Trebicka J; Appenrodt B; Schepke M; Fimmers R;
Gastroenterology; 2015 Sep; 149(3):660-8.e1. PubMed ID: 25989386
[TBL] [Abstract][Full Text] [Related]
11. Hepatic venous pressure gradient predicts clinical decompensation in patients with compensated cirrhosis.
Ripoll C; Groszmann R; Garcia-Tsao G; Grace N; Burroughs A; Planas R; Escorsell A; Garcia-Pagan JC; Makuch R; Patch D; Matloff DS; Bosch J;
Gastroenterology; 2007 Aug; 133(2):481-8. PubMed ID: 17681169
[TBL] [Abstract][Full Text] [Related]
12. Non-selective β-blockers improve the correlation of liver stiffness and portal pressure in advanced cirrhosis.
Reiberger T; Ferlitsch A; Payer BA; Pinter M; Homoncik M; Peck-Radosavljevic M;
J Gastroenterol; 2012 May; 47(5):561-8. PubMed ID: 22170417
[TBL] [Abstract][Full Text] [Related]
13. Preventing first variceal hemorrhage in cirrhosis.
Albillos A
J Clin Gastroenterol; 2007; 41 Suppl 3():S305-11. PubMed ID: 17975481
[TBL] [Abstract][Full Text] [Related]
14. Endoscopic cyanoacrylate injection versus beta-blocker for secondary prophylaxis of gastric variceal bleed: a randomised controlled trial.
Mishra SR; Chander Sharma B; Kumar A; Sarin SK
Gut; 2010 Jun; 59(6):729-35. PubMed ID: 20551457
[TBL] [Abstract][Full Text] [Related]
15. A Prognostic Strategy Based on Stage of Cirrhosis and HVPG to Improve Risk Stratification After Variceal Bleeding.
La Mura V; Garcia-Guix M; Berzigotti A; Abraldes JG; García-Pagán JC; Villanueva C; Bosch J
Hepatology; 2020 Oct; 72(4):1353-1365. PubMed ID: 31960441
[TBL] [Abstract][Full Text] [Related]
16. Right atrial pressure is not adequate to calculate portal pressure gradient in cirrhosis: a clinical-hemodynamic correlation study.
La Mura V; Abraldes JG; Berzigotti A; Erice E; Flores-Arroyo A; García-Pagán JC; Bosch J
Hepatology; 2010 Jun; 51(6):2108-16. PubMed ID: 20512998
[TBL] [Abstract][Full Text] [Related]
17. Relationship between the hepatic venous pressure gradient and first variceal hemorrhage in patients with cirrhosis: a multicenter retrospective study in Korea.
Kim JN; Sohn KM; Kim MY; Suk KT; Jeong SW; Jung HE; Lee SH; Kim SG; Jang JY; Kim YS; Baik SK; Kim HS; Kim DJ; Kim BS
Clin Mol Hepatol; 2012 Dec; 18(4):391-6. PubMed ID: 23323255
[TBL] [Abstract][Full Text] [Related]
18. Propranolol in primary and secondary prophylaxis of variceal bleeding among cirrhotics in India: a hemodynamic evaluation.
De BK; Sen S; Biswas PK; Sengupta D; Biswas J; Santra A; Hazra B; Maity AK
Am J Gastroenterol; 2000 Aug; 95(8):2023-8. PubMed ID: 10950052
[TBL] [Abstract][Full Text] [Related]
19. Non-invasive response prediction in prophylactic carvedilol therapy for cirrhotic patients with esophageal varices.
Kim HY; So YH; Kim W; Ahn DW; Jung YJ; Woo H; Kim D; Kim MY; Baik SK
J Hepatol; 2019 Mar; 70(3):412-422. PubMed ID: 30389550
[TBL] [Abstract][Full Text] [Related]
20. Clinical significance of worsening portal hypertension during long-term medical treatment in patients with cirrhosis who had been classified as early good-responders on haemodynamic criteria.
Merkel C; Bolognesi M; Berzigotti A; Amodio P; Cavasin L; Casarotto IM; Zoli M; Gatta A
J Hepatol; 2010 Jan; 52(1):45-53. PubMed ID: 19914730
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
